NCT06611111View on ClinicalTrials.gov

Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Post-Treatment Lyme Disease
Interventions
DRUG

Ceftriaxone (Rocephin®)

Slightly yellow liquid.

DRUG

Dextrose 5% (D5W)

Colorless liquid

Trial Locations (1)

13057

RECRUITING

SUNY Upstate Medical University, Upstate Global Health Institute, East Syracuse

All Listed Sponsors
collaborator

Steven & Alexandra Cohen Foundation

OTHER

lead

State University of New York - Upstate Medical University

OTHER